TP53 and nasopharyngeal carcinoma: Finally, the top predicted protein TP53 was downregulated in MDA-MB-231(NPC) (Fig. 5h, Supplementary Fig. S6), but not significant in basal-like breast cancer cells (MDA-MB-231, BT549, HS578T) combined.